156 related articles for article (PubMed ID: 29470146)
1. Toward an effective peripheral visceral analgesic: responding to the national opioid crisis.
Camilleri M
Am J Physiol Gastrointest Liver Physiol; 2018 Jun; 314(6):G637-G646. PubMed ID: 29470146
[TBL] [Abstract][Full Text] [Related]
2. Transient receptor potential ion channel function in sensory transduction and cellular signaling cascades underlying visceral hypersensitivity.
Balemans D; Boeckxstaens GE; Talavera K; Wouters MM
Am J Physiol Gastrointest Liver Physiol; 2017 Jun; 312(6):G635-G648. PubMed ID: 28385695
[TBL] [Abstract][Full Text] [Related]
3. Cebranopadol: a novel potent analgesic nociceptin/orphanin FQ peptide and opioid receptor agonist.
Linz K; Christoph T; Tzschentke TM; Koch T; Schiene K; Gautrois M; Schröder W; Kögel BY; Beier H; Englberger W; Schunk S; De Vry J; Jahnel U; Frosch S
J Pharmacol Exp Ther; 2014 Jun; 349(3):535-48. PubMed ID: 24713140
[TBL] [Abstract][Full Text] [Related]
4. Antihyperalgesic, Antiallodynic, and Antinociceptive Effects of Cebranopadol, a Novel Potent Nociceptin/Orphanin FQ and Opioid Receptor Agonist, after Peripheral and Central Administration in Rodent Models of Neuropathic Pain.
Tzschentke TM; Linz K; Frosch S; Christoph T
Pain Pract; 2017 Nov; 17(8):1032-1041. PubMed ID: 28112482
[TBL] [Abstract][Full Text] [Related]
5. Opioid Receptors Contribute to Antinociceptive Effect of Tianeptine on Colorectal Distension-Induced Visceral Pain in Rats.
Bilge SS; İlkaya F; Darakcı Ö; Çiftcioğlu E; Bozkurt A
Pharmacology; 2018; 101(1-2):96-103. PubMed ID: 29141251
[TBL] [Abstract][Full Text] [Related]
6. Antinociceptive Effect of Ghrelin in a Rat Model of Irritable Bowel Syndrome Involves TRPV1/Opioid Systems.
Mao Y; Li Z; Chen K; Yu H; Zhang S; Jiang M; Ma Y; Liang C; Liu H; Li H; Hua Q; Zhou H; Sun Y; Fan X
Cell Physiol Biochem; 2017; 43(2):518-530. PubMed ID: 28930716
[TBL] [Abstract][Full Text] [Related]
7. A novel orvinol analog, BU08028, as a safe opioid analgesic without abuse liability in primates.
Ding H; Czoty PW; Kiguchi N; Cami-Kobeci G; Sukhtankar DD; Nader MA; Husbands SM; Ko MC
Proc Natl Acad Sci U S A; 2016 Sep; 113(37):E5511-8. PubMed ID: 27573832
[TBL] [Abstract][Full Text] [Related]
8. A role for cannabinoid receptors, but not endogenous opioids, in the antinociceptive activity of the CB2-selective agonist, GW405833.
Whiteside GT; Gottshall SL; Boulet JM; Chaffer SM; Harrison JE; Pearson MS; Turchin PI; Mark L; Garrison AE; Valenzano KJ
Eur J Pharmacol; 2005 Dec; 528(1-3):65-72. PubMed ID: 16316650
[TBL] [Abstract][Full Text] [Related]
9. Nociceptin/orphanin FQ opioid peptide (NOP) receptor and µ-opioid peptide (MOP) receptors both contribute to the anti-hypersensitive effect of cebranopadol in a rat model of arthritic pain.
Schiene K; Schröder W; Linz K; Frosch S; Tzschentke TM; Jansen U; Christoph T
Eur J Pharmacol; 2018 Aug; 832():90-95. PubMed ID: 29753041
[TBL] [Abstract][Full Text] [Related]
10. Endogenous opiates and behavior: 2012.
Bodnar RJ
Peptides; 2013 Dec; 50():55-95. PubMed ID: 24126281
[TBL] [Abstract][Full Text] [Related]
11. Research progress on the potential novel analgesic BU08028.
Wang Y; Qin D; Guo Z; Shi F; Cannella N; Ciccocioppo R; Li H
Eur J Pharmacol; 2022 Jan; 914():174678. PubMed ID: 34875275
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological evaluation of NSAID-induced gastropathy as a "Translatable" model of referred visceral hypersensitivity.
Hummel M; Knappenberger T; Reilly M; Whiteside GT
World J Gastroenterol; 2017 Sep; 23(33):6065-6076. PubMed ID: 28970722
[TBL] [Abstract][Full Text] [Related]
13. RGS proteins as targets in the treatment of intestinal inflammation and visceral pain: New insights and future perspectives.
Salaga M; Storr M; Martemyanov KA; Fichna J
Bioessays; 2016 Apr; 38(4):344-54. PubMed ID: 26817719
[TBL] [Abstract][Full Text] [Related]
14. Effects of opioids, cannabinoids, and vanilloids on body temperature.
Rawls SM; Benamar K
Front Biosci (Schol Ed); 2011 Jun; 3(3):822-45. PubMed ID: 21622235
[TBL] [Abstract][Full Text] [Related]
15. Versatile Picklocks To Access All Opioid Receptors: Tuning the Selectivity and Functional Profile of the Cyclotetrapeptide c[Phe-d-Pro-Phe-Trp] (CJ-15,208).
De Marco R; Bedini A; Spampinato S; Cavina L; Pirazzoli E; Gentilucci L
J Med Chem; 2016 Oct; 59(19):9255-9261. PubMed ID: 27607020
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of sensory afferents activation and visceral pain by a brominated algal diterpene.
Chatter R; Cenac N; Roussis V; Kharrat R; Vergnolle N
Neurogastroenterol Motil; 2012 Jul; 24(7):e336-43. PubMed ID: 22709240
[TBL] [Abstract][Full Text] [Related]
17. Orally administered novel cyclic pentapeptide P-317 alleviates symptoms of diarrhoea-predominant irritable bowel syndrome.
Zielińska M; Chen C; Mokrowiecka A; Cygankiewicz AI; Zakrzewski PK; Sałaga M; Małecka-Panas E; Wlaź P; Krajewska WM; Fichna J
J Pharm Pharmacol; 2015 Feb; 67(2):244-54. PubMed ID: 25515402
[TBL] [Abstract][Full Text] [Related]
18. Transient receptor potential cation channels in visceral sensory pathways.
Blackshaw LA
Br J Pharmacol; 2014 May; 171(10):2528-36. PubMed ID: 24641218
[TBL] [Abstract][Full Text] [Related]
19. Review article: transient receptor potential channels as possible therapeutic targets in irritable bowel syndrome.
Beckers AB; Weerts ZZRM; Helyes Z; Masclee AAM; Keszthelyi D
Aliment Pharmacol Ther; 2017 Nov; 46(10):938-952. PubMed ID: 28884838
[TBL] [Abstract][Full Text] [Related]
20. Involvement of opioid receptors in the systemic and peripheral antinociceptive actions of montelukast in the animal models of pain.
Ghorbanzadeh B; Mansouri MT; Sahraei H; Alboghobeish S
Eur J Pharmacol; 2016 May; 779():38-45. PubMed ID: 26948314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
